Welcome to the Smart Slider Template Library! Here, you’ll find a curated collection of design templates.
MMIT offers a range of publications for pharma, payers and providers covering news, strategy and insights across the spectrum. Our in-house journalism division AIS Health provides objective news and analysis of industry trends while RJ Health provides a comprehensive look at industry updates as they apply to medically covered drug reimbursement processes.
We are the leading provider of real-world data, expertise and insights.
We deliver a 360-degree view of the full patient journey.
Our data and market research offerings provide a simplified view into the market.
Understand your place in the market and how to grow your business.
With NorstellaLinQ, MMIT delivers clarity, confidence, and speed with tailored solutions. Whether you’re a fast-growing biotech or an industry leader, our expert support empowers you to strengthen your strategy, act faster, and achieve better outcomes.
Powered by NorstellaLinQ, MMIT helps you track a patient cohort from diagnosis to treatment, noting the critical events and triggers along the way—from test results to payer restrictions that impact provider behavior.
Business Questions
Business Questions
Business Questions
Patients who have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer over a given time period.
Patients who have successfully completed a frontline platinum-based regimen.
Patients who are in remission and haven’t moved on to a second therapy.
Patients in remission who are actively being managed and maintain levels through lab testing (Cancer Antigen / CA 125).
Eligible patients at Texas Oncology.
Validate product fit market assumptions to determine your price point and launch strategy.
Set realistic expectations around how and when coverage will occur, and what restrictions are likely.
Track policy updates and monitor key accounts in the hectic post-launch timeframe.
Our customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.
Establish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.
Let our unbeatable covered lives methodology and innovative technology inform your market access strategy.
Our customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.
Establish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.
Let our unbeatable covered lives methodology and innovative technology inform your market access strategy.
As one small biopharma company awaited FDA approval, it partnered with MMIT to do its homework on market dynamics to ensure immediate patient access to its oncology therapies.
In this case study, learn how MMIT’s claims, coverage and restriction data helped the company better understand payer mix and utilization analytics so they could prepare to take on their competitors. In this case study, learn how MMIT’s claims, coverage and restriction data helped the company better understand payer mix and utilization analytics so they could prepare to take on their competitors.
Validate product fit market assumptions to determine your price point and launch strategy.
Set realistic expectations around how and when coverage will occur, and what restrictions are likely.
Track policy updates and monitor key accounts in the hectic post-launch timeframe.
As market access challenges grow, pharma companies are beginning their pre-launch planning much earlier in the product lifecycle. But what can pharma companies hope to learn about the competitive landscape so far in advance? This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.
How historic analogs can help your team decide whether to pursue or license a product.
When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
What kind of data helps you anticipate (and circumvent) launch disadvantages.
Powerful Analytics Solutions and Easy-to-Use Technology
Access industry-leading pharmacy benefit data derived from payers' drug lists to understand basic coverage data, such as whether a drug is covered and what restrictions (such as step therapy and prior authorization) are in place.
Gain deeper insight into the patient journey with comprehensive pharmacy and/or medical policy data. This powerful tool helps clients understand how a brand is covered across payers with multiple benefit designs, channels, contracting relationships, subsidiaries and other attributes.
Leverage MMIT's strong analytical and insights capabilities to create executive summary market overview reports highlighting key takeaways from the expansive PAR dataset. The extra service layer also includes expertise from MMIT's team and customized deliverables to meet unique business questions.
MMIT provides bi-weekly market snapshots, office hours, and expedited answers to client queries from a dedicated market access advisor with the Analytics Pro solution and services bundle.
As market access challenges grow, pharma companies are beginning their pre-launch planning much earlier in the product lifecycle. But what can pharma companies hope to learn about the competitive landscape so far in advance? This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.
How historic analogs can help your team decide whether to pursue or license a product.
When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
What kind of data helps you anticipate (and circumvent) launch disadvantages.
Gain comprehensive insight into formulary and medical benefit coverage, covered lives, and policy and restriction information.
Real-world data informs pharma companies’ decision-making across the development lifecycle. In this infographic, see what percentage of manufacturers are using RWD in each phase, and for what purposes.
As one small biopharma company awaited FDA approval, it partnered with MMIT to do its homework on market dynamics to ensure immediate patient access to its oncology therapies.
In this case study, learn how MMIT’s claims, coverage and restriction data helped the company better understand payer mix and utilization analytics so they could prepare to take on their competitors. In this case study, learn how MMIT’s claims, coverage and restriction data helped the company better understand payer mix and utilization analytics so they could prepare to take on their competitors.
Validate product fit market assumptions to determine your price point and launch strategy.
Set realistic expectations around how and when coverage will occur, and what restrictions are likely.
Track policy updates and monitor key accounts in the hectic post-launch timeframe.
Your infographic is now available using the link below.
MMIT, powered by NorstellaLinQ, integrates coverage data, claims data, lab results, and EMR with NPI tied back to prescribers and healthcare facilities, to deliver unmatched granularity into patient journeys, provider behavior, and payer decision-making.
Make Better Decisions With Complete Coverage Data
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.
Make Better Decisions With Complete Coverage Data
Powered by NorstellaLinQ, MMIT's HCP and Patient Targeting Solution uses structured and unstructured data to pinpoint hard-to-find patients and their treating providers.
Make Better Decisions With Complete Coverage Data
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
Make Better Decisions With Complete Coverage Data
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.
Make Better Decisions With Complete Coverage Data
Powered by NorstellaLinQ, Trigger Alerts surface high-value patients and their treating physicians within days of a clinical event—so you can act while it still matters.
Make Better Decisions With Complete Coverage Data
LinQNotes is an exploratory tool that allows users to search and interact with unstructured clinical data, giving your commercial and market access teams instant context into how patient care is navigated to uncover directional insights that inform commercial strategy.